This brand name is authorized in Austria, Canada, Ecuador, Finland, Poland, Spain, UK.
The drug ZEVTERA contains one active pharmaceutical ingredient (API):
1
|
UNII
N99027V28J - CEFTOBIPROLE MEDOCARIL
|
|
Ceftobiprole exerts bactericidal activity through binding to important penicillin-binding proteins (PBPs) in susceptible species. |
|
Below package inserts are available for further reading:
| Document | Type | Information Source | |
|---|---|---|---|
| ZEVTERA Powder for concentrate for solution for infusion | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| J01DI01 | Ceftobiprole medocaril | J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DI Other cephalosporins |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| CA | Health Products and Food Branch | 02446685 |
| EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | 5083-MEE-0420 |
| ES | Centro de información online de medicamentos de la AEMPS | 78691 |
| FI | Lääkealan turvallisuus- ja kehittämiskeskus | 461122 |
| GB | Medicines & Healthcare Products Regulatory Agency | 310137 |
| PL | Rejestru Produktów Leczniczych | 100385920 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.